Research Article
Contrast-Enhanced Ultrasound Guided Biopsy of Undetermined Abdominal Lesions: A Multidisciplinary Decision-Making Approach
Table 1
Baseline characteristics of patients in two groups.
| Characteristic | CEUS group () | US group () |
| Age (year) | | | Mean ± SD | | | Range | 17–83 | 16–80 | Male/female | 37/23 | 43/32 | Underlying diseases | | | Previous tumor history | 7 | 8 | None | 53 | 67 | CEA (ng/mL) | | | ≤5, (%) | 45 (75.0%) | 34 (45.3%) | >5, (%) | 15 (25%) | 41 (54.7%) | CA 19-9 (μ/mL) | | | ≤4.9, (%) | 25 (41.6%) | 51 (68.0%) | >4.9, (%) | 35 (58.4%) | 24 (32.0%) | Initial clinical diagnose | | | Malignant, (%) | 56 (93.3%) | 70 (93.3%) | Benign, (%) | 4 (6.7%) | 5 (6.7%) |
|
|
CEA: carcinoembryonic antigen; CA19-9: carbohydrate antigen 19-9.
|